share_log

Regeneron Pharmaceuticals | SC TO-T/A: Third party tender offer statement (Amendment)

SEC ·  May 31, 2022 20:38
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.